Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DCAF12L2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | DCHS2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | MTG2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | CMC1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | RDH13 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
mRNA | SEPT5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | GK | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | PRKX | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | BRF2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | TTC1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |